Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic : responsible stewardship is needed

Schaaf, H. S. ; Du Preez, K. ; Kruger, M. ; Solomons, R. ; Taljaard, J. J. ; Rabie, H. ; Seddon, J. A. ; Cotton, M. F. ; Tebruegge, M. ; Curtis, N. ; Hesseling, A. C. (2020)

CITATION: Schaaf, H. S. et al. 2020. Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic : responsible stewardship is needed. International Journal of Tuberculosis and Lung Disease, 4(7):732-734, doi:10.5588/ijtld.20.0267.

The original publication is available at https://www.theunion.org/what-we-do/journals/ijtld

Article

We believe that responsible stewardship of the bacille Calmette-Guérin (BCG) vaccine in the context of the COVID-19 epidemic is urgently needed. Live attenuated BCG is currently the only licensed vaccine to protect against tuberculosis (TB). Neonatal BCG vaccination has proven efficacy in protecting infants and young children against life-threatening disseminated forms of TB, including TB meningitis and miliary TB.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/108787
This item appears in the following collections: